DJ Fang, chief operating officer and co-founder of AI-powered regulatory consultancy Pure Global, says softer regulations in China and Southeast Asia can mean readier access to patient data, which is in growing demand as medtechs and their partners work to train AI algorithms.
Compared with the US and Europe where regulations around data privacy and informed consent are more stringent, “what you find...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?